ISRCTN40371122已完成1 期
Phase 1 Trial: Fortrea
JAZZ Pharmaceuticals Research UK Ltd0 个研究点目标入组 96 人开始时间: 2024年6月27日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 96
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.
排除标准
- •The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.
研究者
相似试验
已完成
1 期
Phase I trial: Fortrea code: 8476207Healthy volunteersISRCTN88307799Vifor (International) Inc.8
招募中
不适用
The trial to evaluate the safety and efficacy of high dose ambroxol in combination with enzyme replacement therapy in Gaucher disease patientsEndocrine, nutritional and metabolic diseaseKCT0003218Asan Medical Center10
进行中（未招募）
1 期
A PHASE II, SINGLE-ARMED, MULTICENTER TRIAL OF NEOADJUVANT VISMODEGIB IN PATIENTS WITH LARGE AND/OR RECURRENT RESECTABLE BASAL CELL CARCINOMA - NICCIEUCTR2016-002856-26-DESRH Wald-Klinikum Gera GmbH40
进行中（未招募）
1 期
The CONFRONT Phase I – II Trial: ACtivatiON oF immune RespONse in paTients with R-M Head and Neck Cancer. Multimodality immunotherapy with Avelumab, short course radiotherapy and Cyclophosphamide in Head and Neck cancer.R-M Head and Neck CancerMedDRA version: 20.0Level: PTClassification code 10034813Term: Pharyngeal cancer recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10055104Term: Pharyngeal cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2017-000353-39-ITG.O.N.O. - GRUPPO ONCOLOGICO DEL NORD OVEST71
进行中（未招募）
Unknown
The Trial to Evaluate the Safety and Efficacy and to Extend the Evaluation Period of High dose Ambroxol in Combination with Enzyme Replacement Therapy in Gaucher Disease PatientsEndocrine, nutritional and metabolic diseasesKCT0009450Asan Medical Center10